TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Outrage as Teva charges $18,275 for generic drug in US - The Jerusalem Post
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva Pharmaceutical Industries Ltd | Reuters
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OMAQFWFHNJDZCDZKKO5DWLBG4.jpg "Teva Israel enters medical cannabis market with new partnership | Reuters")
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva says vaccine makers have not taken its offer to help produce jabs | Financial Times
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 By Reuters
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva Stops Production At US Plant After FDA Concerns: Report
US Supreme Court sides with Teva in drug dispute
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva shares tumble amid political battle, doubt from Moody's
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
The logo of Teva Pharmaceutical Industries is seen on a part of their building in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
What's 'down' with Teva? - The Jerusalem Post
Teva buys Anda for $500 million - ISRAEL21c
Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net
Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on
